SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-027737
Filing Date
2022-10-05
Accepted
2022-10-05 17:27:49
Documents
15
Period of Report
2022-09-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44183
2 ex99-1.htm EX-99.1 11305
3 ex99-1_001.jpg GRAPHIC 12923
  Complete submission text file 0001493152-22-027737.txt   297107

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hrow-20220930.xsd EX-101.SCH 3950
5 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hrow-20220930_def.xml EX-101.DEF 27023
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hrow-20220930_lab.xml EX-101.LAB 37280
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hrow-20220930_pre.xml EX-101.PRE 25644
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5542
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 221296559
SIC: 2834 Pharmaceutical Preparations